Question 1

Does MetLife Investment Management own SAVA stock?

Accepted Answer

No. MetLife Investment Management exited its SAVA (Filana Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 22,699 shares worth $668,032.

Question 2

How many shares of SAVA does MetLife Investment Management own?

Accepted Answer

None since Q4 2024, when MetLife Investment Management exited the position. Its Q3 2024 13F listed 22,699 shares worth $668,032.

Question 3

What is MetLife Investment Management's SAVA position worth?

Accepted Answer

MetLife Investment Management's SAVA position was worth $668,032 in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is MetLife Investment Management buying or selling SAVA?

Accepted Answer

In Q4 2024, MetLife Investment Management exited its entire SAVA position.

Question 5

When did MetLife Investment Management first buy SAVA?

Accepted Answer

MetLife Investment Management first reported SAVA in its Q4 2020 13F and listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$2.36	0
2024-Q3	Unchanged	22,699	0.0%	$668,032	0.0%	$29.43	0